Processos criativos: a importância do olhar

Pesquisas realizadas recentemente salientam o papel desempenhado pelas emoções no cerne dos processos cognitivos e, em particular, na criatividade, entendendo esta não como uma faculdade mas como um processo complexo e dinâmico, dependente de vários fatores intrínsecos e extrínsecos ao sujeito. Paralelamente, a abordagem pedagógica no domínio das artes modificou-se consideravelmente desde os anos 80, desviando a atenção da produção para o processo de conhecimento e o seu conteúdo. Essa alteração levou a uma mudança de paradigma: em vez de se introduzir cegamente os alunos nos detalhes e métodos da produção artística, isolando estes do seu contexto social, procura-se agora despertar neles o olhar estético. Como em Duchamp, tenta-se alcançar uma viragem qualitiva, do objeto para o contexto.Abstract: In the past few years, scientific research has placed emotional states at the heart of general cognitive processes, with a special focus on creativity, which ceased to be understood as an inherent faculty in itself, and seen as a complex and dynamic process, depending on various factors, both internal and external to the self. In a similar manner, the way we teach art has considerably changed, especially since the 1980’s, when more attention started being paid to content and to the process of understanding, instead of the emphasis being placed on production. In essence, you could say there has been a change in paradigm. Instead of blindly immersing students in the details and methods of artistic production, in isolation from their social context, we now strive to awaken their aesthetic sense. Like Duchamp, we attempt a qualitative shift, from object to context.Résumé: Des recherches menées au cours des dernières années sont venues mettre en évidence le rôle joué par les émotions au centre des processus cognitifs, en particulier, la créativité. Celle-ci est passée graduellement du statut de faculté, à celui d’un processus complexe, qui dépend à la fois de facteurs internes et externes à l’individu lui-même. Parallèlement, l’abordage pédagogique dans le domaine des arts a considérablement changé depuis les années 1980, rehaussant l’importance du contenu et du travail de compréhension, s’écartant de l’emphase portée sur la production. On peut évoquer une transition de paradigme. Au lieu d’introduire aveuglement les étudiants dans les détails et méthodes de production artistique, en isolant ceux-ci de leur contexte social, on s’efforce d’éveiller chez eux l’oeil esthétique. Comme Duchamp, on essaye un saut qualitatif, de l’objet au contenu/contexte

Estudos Artísticos

Arte em transe. De um modo especializado, dentro do projeto criadores sobre outras obras, a revista Croma interessa-se pela implicação, a intervenção, e a valorização. Nesta sétima edição reuniram-se 17 artigos que tomam como ponto comum a abordagem de obras que exigem diferentes formas de participação. As propostas artísticas não funcionam sem a interação das pessoas. O seu suporte vital, funcional, o seu sentido, estas dimensões, materiais e imateriais, convergem para as pessoas vivas que com elas atuam. Sobre estes artigos podemos promover diferentes abordagens. Mas interessará estudar o que motivou os temas apresentados. Podem detetar-se regularidades dentro dos espaços de implicação que privilegiamos na revista Croma. Quais são estas regularidades? Encontramos alguns núcleos problematizadores comuns: o género, a inclusão, a migração, o corpo, a identidade.info:eu-repo/semantics/publishedVersio

Critical thinking development : gender issues in the context of arts training in higher education

Este artigo pretende analisar o desenvolvimento do pensamento crítico sobre questões de género no contexto da formação no ensino superior, tomando como caso de estudo a proposta “Género(s)”, que visou a realização de um projeto transdisciplinar articulado entre as Unidades Curriculares de Oficina de Artes, Tecnologias e Multimédia IV (OATM IV) - módulos de Escultura e Arte Multimédia - e de Teoria da Arte, do 2º semestre do ano letivo de 2019/2020, promovendo a reflexão sobre a questão de género e o pensamento crítico dos estudantes de Licenciatura em Artes Visuais e Tecnologias da Escola Superior de Educação do Politécnico de Lisboa. No decorrer do processo, os professores assumiram um papel de facilitadores, criando um espaço livre de censura e constatando que os estudantes mobilizaram e desenvolveram o pensamento crítico em processos de investigação e criação artística em torno de estereótipos sobre questões de género. A imaginação de diferentes possibilidades de géneros levou a uma reflexão sobre os valores enquanto construções culturais e à consciência do agenciamento de cada um para os reinventar e contribuir para a mudança social. Deste modo, consideramos que a produção artística e/ou a interpretação de obras de arte estimulam o pensamento autónomo, capaz de lidar com situações novas, através da projeção de várias hipóteses alternativas. Concluímos, assim, que a educação artística é um espaço privilegiado para estimular o desenvolvimento do pensamento crítico, sem recorrer a ideias pré-concebidas, sendo por isso potencialmente apto a combater os estereótipos de classe, cultura ou género e, deste modo, contribuir para a criação de valores orientadores de uma ação socialmente justa.ABSTRACT: This study aims to analyze the development of critical thinking on gender issues in the context of higher education training, taking as a case study the work proposal “Gender(s)” which aimed to carry out a transdisciplinary project articulated between the Curricular Units of Workshop of Arts, Technologies and Multimedia IV (OATM IV) - Sculpture and Multimedia Art modules - and Art Theory, of the 2nd semester of the academic year 2019/2020, promoting reflection on the issue of Gender and critical thinking of undergraduate students in Visual Arts and Technologies of the School of Education of the Polytechnic of Lisbon. The aim of this project is to promote reflection on the gender issue and critical thinking among undergraduate Visual Arts and Technologies students at the School of Education of the Polytechnic of Lisbon.During the process, teachers assumed the role of facilitators, creating a space free of censorship, finding that students mobilized and developed critical thinking, in processes of investigation and artistic creation around gender stereotypes. The imagination of ferent gender possibilities led to a reflection about values as cultural constructions and to the awareness of each one’s agency to rein-vent them and contribute to social change. In this way, we consider that artistic production and/or interpretation of art works stimulate autonomous thinking, capable of dealing with new situations, through the projection of several alternative hypotheses. We conclude, therefore, that art education is a privileged space to stimulate the development of critical thinking, without resorting to preconceived ideas, being, therefore, potentially able to combat class, culture or gender stereotypes and, in this way, contri-bute to the creation of values that guide a socially fair action.info:eu-repo/semantics/publishedVersio

Gas6 drives Zika virus-induced neurological complications in humans and congenital syndrome in immunocompetent mice

Zika virus (ZIKV) has the ability to cross placental and brain barriers, causing congenital malformations in neonates and neurological disorders in adults. However, the pathogenic mechanisms of ZIKV-induced neurological complications in adults and congenital malformations are still not fully understood. Gas6 is a soluble TAM receptor ligand able to promote flavivirus internalization and downregulation of immune responses. Here we demonstrate that there is a correlation between ZIKV neurological complications with higher Gas6 levels and the downregulation of genes associated with anti-viral response, as type I IFN due to Socs1 upregulation. Also, Gas6 gamma-carboxylation is essential for ZIKV invasion and replication in monocytes, the main source of this protein, which was inhibited by warfarin. Conversely, Gas6 facilitates ZIKV replication in adult immunocompetent mice and enabled susceptibility to transplacental infection. Our data indicate that ZIKV promotes the upregulation of its ligand Gas6, which contributes to viral infectivity and drives the development of severe adverse outcomes during ZIKV infection

Em busca de um horizonte : narrativas sobre educação, artes e resistência

"APRESENTAÇÃO - Os textos reunidos no livro Em busca de um Horizonte: narrativas sobre educação, arte e resistência foram inspirados nos debates realizados durante o evento VI Simpósio Internacional Horizontes Humanos, que aconteceu na Faculdade de Educação da Universidade de Brasília, em 2018. O livro está dividido em quatro partes: Resistências cotidianas para além da utopia, Demasiado humano: as diferentes linguagens artísticas e culturais, A educação como um horizonte, Educação ambiental e ancestralidade: para continuar caminhando. Apesar da divisão em seções (sempre arbitrária), as produções - bastante diversas nas temáticas, metodologias e referenciais teóricos adotados – compartilham um alinhamento ao adotar um posicionamento político em defesa da diversidade, dos direitos humanos, da ancestralidade, do meio ambiente, da educação com valores democráticos, dos saberes populares e das diferentes linguagens artísticas. Assim, o livro se apresenta como um convite à resistência em tempos atrozes. Os organizadores

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Background: Sparsentan is a novel, non-immunosuppressive, single-molecule, dual endothelin and angiotensin receptor antagonist being examined in an ongoing phase 3 trial in adults with IgA nephropathy. We report the prespecified interim analysis of the primary proteinuria efficacy endpoint, and safety. Methods: PROTECT is an international, randomised, double-blind, active-controlled study, being conducted in 134 clinical practice sites in 18 countries. The study examines sparsentan versus irbesartan in adults (aged ≥18 years) with biopsy-proven IgA nephropathy and proteinuria of 1·0 g/day or higher despite maximised renin-angiotensin system inhibitor treatment for at least 12 weeks. Participants were randomly assigned in a 1:1 ratio to receive sparsentan 400 mg once daily or irbesartan 300 mg once daily, stratified by estimated glomerular filtration rate at screening (30 to 1·75 g/day). The primary efficacy endpoint was change from baseline to week 36 in urine protein-creatinine ratio based on a 24-h urine sample, assessed using mixed model repeated measures. Treatment-emergent adverse events (TEAEs) were safety endpoints. All endpoints were examined in all participants who received at least one dose of randomised treatment. The study is ongoing and is registered with ClinicalTrials.gov, NCT03762850. Findings: Between Dec 20, 2018, and May 26, 2021, 404 participants were randomly assigned to sparsentan (n=202) or irbesartan (n=202) and received treatment. At week 36, the geometric least squares mean percent change from baseline in urine protein-creatinine ratio was statistically significantly greater in the sparsentan group (-49·8%) than the irbesartan group (-15·1%), resulting in a between-group relative reduction of 41% (least squares mean ratio=0·59; 95% CI 0·51-0·69; p<0·0001). TEAEs with sparsentan were similar to irbesartan. There were no cases of severe oedema, heart failure, hepatotoxicity, or oedema-related discontinuations. Bodyweight changes from baseline were not different between the sparsentan and irbesartan groups. Interpretation: Once-daily treatment with sparsentan produced meaningful reduction in proteinuria compared with irbesartan in adults with IgA nephropathy. Safety of sparsentan was similar to irbesartan. Future analyses after completion of the 2-year double-blind period will show whether these beneficial effects translate into a long-term nephroprotective potential of sparsentan. Funding: Travere Therapeutics

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

BackgroundSparsentan, a novel, non-immunosuppressive, single-molecule, dual endothelin angiotensin receptor antagonist, significantly reduced proteinuria versus irbesartan, an angiotensin II receptor blocker, at 36 weeks (primary endpoint) in patients with immunoglobulin A nephropathy in the phase 3 PROTECT trial's previously reported interim analysis. Here, we report kidney function and outcomes over 110 weeks from the double-blind final analysis.MethodsPROTECT, a double-blind, randomised, active-controlled, phase 3 study, was done across 134 clinical practice sites in 18 countries throughout the Americas, Asia, and Europe. Patients aged 18 years or older with biopsy-proven primary IgA nephropathy and proteinuria of at least 1·0 g per day despite maximised renin–angiotensin system inhibition for at least 12 weeks were randomly assigned (1:1) to receive sparsentan (target dose 400 mg oral sparsentan once daily) or irbesartan (target dose 300 mg oral irbesartan once daily) based on a permuted-block randomisation method. The primary endpoint was proteinuria change between treatment groups at 36 weeks. Secondary endpoints included rate of change (slope) of the estimated glomerular filtration rate (eGFR), changes in proteinuria, a composite of kidney failure (confirmed 40% eGFR reduction, end-stage kidney disease, or all-cause mortality), and safety and tolerability up to 110 weeks from randomisation. Secondary efficacy outcomes were assessed in the full analysis set and safety was assessed in the safety set, both of which were defined as all patients who were randomly assigned and received at least one dose of randomly assigned study drug. This trial is registered with ClinicalTrials.gov, NCT03762850.FindingsBetween Dec 20, 2018, and May 26, 2021, 203 patients were randomly assigned to the sparsentan group and 203 to the irbesartan group. One patient from each group did not receive the study drug and was excluded from the efficacy and safety analyses (282 [70%] of 404 included patients were male and 272 [67%] were White) . Patients in the sparsentan group had a slower rate of eGFR decline than those in the irbesartan group. eGFR chronic 2-year slope (weeks 6–110) was −2·7 mL/min per 1·73 m2 per year versus −3·8 mL/min per 1·73 m2 per year (difference 1·1 mL/min per 1·73 m2 per year, 95% CI 0·1 to 2·1; p=0·037); total 2-year slope (day 1–week 110) was −2·9 mL/min per 1·73 m2 per year versus −3·9 mL/min per 1·73 m2 per year (difference 1·0 mL/min per 1·73 m2 per year, 95% CI −0·03 to 1·94; p=0·058). The significant reduction in proteinuria at 36 weeks with sparsentan was maintained throughout the study period; at 110 weeks, proteinuria, as determined by the change from baseline in urine protein-to-creatinine ratio, was 40% lower in the sparsentan group than in the irbesartan group (−42·8%, 95% CI −49·8 to −35·0, with sparsentan versus −4·4%, −15·8 to 8·7, with irbesartan; geometric least-squares mean ratio 0·60, 95% CI 0·50 to 0·72). The composite kidney failure endpoint was reached by 18 (9%) of 202 patients in the sparsentan group versus 26 (13%) of 202 patients in the irbesartan group (relative risk 0·7, 95% CI 0·4 to 1·2). Treatment-emergent adverse events were well balanced between sparsentan and irbesartan, with no new safety signals.InterpretationOver 110 weeks, treatment with sparsentan versus maximally titrated irbesartan in patients with IgA nephropathy resulted in significant reductions in proteinuria and preservation of kidney function

Management of coronary disease in patients with advanced kidney disease

BACKGROUND Clinical trials that have assessed the effect of revascularization in patients with stable coronary disease have routinely excluded those with advanced chronic kidney disease. METHODS We randomly assigned 777 patients with advanced kidney disease and moderate or severe ischemia on stress testing to be treated with an initial invasive strategy consisting of coronary angiography and revascularization (if appropriate) added to medical therapy or an initial conservative strategy consisting of medical therapy alone and angiography reserved for those in whom medical therapy had failed. The primary outcome was a composite of death or nonfatal myocardial infarction. A key secondary outcome was a composite of death, nonfatal myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. RESULTS At a median follow-up of 2.2 years, a primary outcome event had occurred in 123 patients in the invasive-strategy group and in 129 patients in the conservative-strategy group (estimated 3-year event rate, 36.4% vs. 36.7%; adjusted hazard ratio, 1.01; 95% confidence interval [CI], 0.79 to 1.29; P=0.95). Results for the key secondary outcome were similar (38.5% vs. 39.7%; hazard ratio, 1.01; 95% CI, 0.79 to 1.29). The invasive strategy was associated with a higher incidence of stroke than the conservative strategy (hazard ratio, 3.76; 95% CI, 1.52 to 9.32; P=0.004) and with a higher incidence of death or initiation of dialysis (hazard ratio, 1.48; 95% CI, 1.04 to 2.11; P=0.03). CONCLUSIONS Among patients with stable coronary disease, advanced chronic kidney disease, and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of death or nonfatal myocardial infarction

Health status after invasive or conservative care in coronary and advanced kidney disease

BACKGROUND In the ISCHEMIA-CKD trial, the primary analysis showed no significant difference in the risk of death or myocardial infarction with initial angiography and revascularization plus guideline-based medical therapy (invasive strategy) as compared with guideline-based medical therapy alone (conservative strategy) in participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease (an estimated glomerular filtration rate of &lt;30 ml per minute per 1.73 m2 or receipt of dialysis). A secondary objective of the trial was to assess angina-related health status. METHODS We assessed health status with the Seattle Angina Questionnaire (SAQ) before randomization and at 1.5, 3, and 6 months and every 6 months thereafter. The primary outcome of this analysis was the SAQ Summary score (ranging from 0 to 100, with higher scores indicating less frequent angina and better function and quality of life). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate the treatment effect with the invasive strategy. RESULTS Health status was assessed in 705 of 777 participants. Nearly half the participants (49%) had had no angina during the month before randomization. At 3 months, the estimated mean difference between the invasive-strategy group and the conservative-strategy group in the SAQ Summary score was 2.1 points (95% credible interval, 120.4 to 4.6), a result that favored the invasive strategy. The mean difference in score at 3 months was largest among participants with daily or weekly angina at baseline (10.1 points; 95% credible interval, 0.0 to 19.9), smaller among those with monthly angina at baseline (2.2 points; 95% credible interval, 122.0 to 6.2), and nearly absent among those without angina at baseline (0.6 points; 95% credible interval, 121.9 to 3.3). By 6 months, the between-group difference in the overall trial population was attenuated (0.5 points; 95% credible interval, 122.2 to 3.4). CONCLUSIONS Participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease did not have substantial or sustained benefits with regard to angina-related health status with an initially invasive strategy as compared with a conservative strategy